Yanong D. Wang

270 Dong An Road
Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

Intraperitoneal and Intravenous Paclitaxel Plus S-1 for Gastric Cancer With Peritoneal Metastasis: A Phase 3 Randomized Clinical Trial.

Intraperitoneal and Intravenous Paclitaxel Plus S-1 for Gastric Cancer With Peritoneal Metastasis: A Phase 3 Randomized Clinical Trial.

Journal: JAMA oncology

Published: May 21, 2026

Design, synthesis, and biological evaluation of a potent and selective AURKB degrader.

Design, synthesis, and biological evaluation of a potent and selective AURKB degrader.

Journal: European journal of medicinal chemistry

Published: April 03, 2026

Preoperative Chemoradiotherapy versus Chemotherapy for Locally Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma: A Phase III Randomized Controlled Trial from China.

Preoperative Chemoradiotherapy versus Chemotherapy for Locally Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma: A Phase III Randomized Controlled Trial from China.

Journal: Cancer communications (London, England)

Published: November 18, 2025

Bismuth-Doped Ag2Te Colloidal Quantum Dots for High-Performance Shortwave-Infrared Photodetectors.

Bismuth-Doped Ag2Te Colloidal Quantum Dots for High-Performance Shortwave-Infrared Photodetectors.

Journal: Inorganic chemistry

Published: July 09, 2025

Asian consensus on normothermic intraperitoneal and systemic treatment for gastric cancer with peritoneal metastasis.

Asian consensus on normothermic intraperitoneal and systemic treatment for gastric cancer with peritoneal metastasis.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: November 25, 2024

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial.

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial.

Journal: The Lancet. Oncology

Published: August 22, 2024

Ferroptosis suppressor genes are highly expressed in esophageal cancer to inhibit tumor cell ferroptosis

Ferroptosis suppressor genes are highly expressed in esophageal cancer to inhibit tumor cell ferroptosis

Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University

Published: July 25, 2024

FAP upregulates PD-L1 expression in cancer-associated fibroblasts to exacerbate T cells dysfunction and suppress anti-tumor immunity.

FAP upregulates PD-L1 expression in cancer-associated fibroblasts to exacerbate T cells dysfunction and suppress anti-tumor immunity.

Journal: Cancer letters

Published: July 16, 2024

An inherited predisposition allele promotes gastric cancer via enhancing deubiquitination-mediated activation of epithelial-to-mesenchymal transition signaling.

An inherited predisposition allele promotes gastric cancer via enhancing deubiquitination-mediated activation of epithelial-to-mesenchymal transition signaling.

Journal: The Journal of clinical investigation

Published: January 23, 2024

Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response.

Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response.

Journal: Nature communications

Published: December 07, 2023

Discovery of potent small molecule inhibitors of histone lysine methyltransferase NSDs.

Discovery of potent small molecule inhibitors of histone lysine methyltransferase NSDs.

Journal: European journal of medicinal chemistry

Published: November 28, 2023

LncRNA-CCAT5-mediated crosstalk between Wnt/β-Catenin and STAT3 signaling suggests novel therapeutic approaches for metastatic gastric cancer with high Wnt activity.

LncRNA-CCAT5-mediated crosstalk between Wnt/β-Catenin and STAT3 signaling suggests novel therapeutic approaches for metastatic gastric cancer with high Wnt activity.

Journal: Cancer communications (London, England)

Published: March 12, 2023

Showing 1-12 of 69

Last Updated: 09/26/2026